Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.61 -0.01 (-2.37%)
As of: Oct 23, 2026 · 1:25 PM EDT

Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023)

Updated

Mira Pharmaceuticals' (MIRA) Debt Ratio was 0.47 for the quarter ended Jun 30, 2023.

Analysis

Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023) Analysis & Trends

For the year ended Dec 31, 2022, Debt Ratio at Mira Pharmaceuticals was 0.16.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn 0.39
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn 0.23
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn 0.52
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn 0.42
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn 0.08
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn 0.28
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn 0.60
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn 0.53
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 0.31
10 Mira Pharmaceuticals 14.55 Mn -5.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 0.47
Dec 31, 2022 0.16
API Access

Mira Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MIRA&period=max&api_key=YOUR_API_KEY